A one-hit model of cell death in inherited neuronal degenerations
Geoff Clarke,
Richard A. Collins,
Blair R. Leavitt,
David F. Andrews,
Michael R. Hayden,
Charles J. Lumsden and
Roderick R. McInnes ()
Additional contact information
Geoff Clarke: Programs in Developmental Biology and Genetics, The Research Institute, Hospital for Sick Children
Richard A. Collins: Departments of Molecular and Medical Genetics
Blair R. Leavitt: Centre for Molecular Medicine and Therapeutics
David F. Andrews: University of Toronto
Michael R. Hayden: Centre for Molecular Medicine and Therapeutics
Charles J. Lumsden: University of Toronto
Roderick R. McInnes: Programs in Developmental Biology and Genetics, The Research Institute, Hospital for Sick Children
Nature, 2000, vol. 406, issue 6792, 195-199
Abstract:
Abstract In genetic disorders associated with premature neuronal death, symptoms may not appear for years or decades. This delay in clinical onset is often assumed to reflect the occurrence of age-dependent cumulative damage1,2,3,4,5,6. For example, it has been suggested that oxidative stress disrupts metabolism in neurological degenerative disorders by the cumulative damage of essential macromolecules1,4,7. A prediction of the cumulative damage hypothesis is that the probability of cell death will increase over time. Here we show in contrast that the kinetics of neuronal death in 12 models of photoreceptor degeneration, hippocampal neurons undergoing excitotoxic cell death8, a mouse model of cerebellar degeneration9 and Parkinson's10 and Huntington's diseases are all exponential and better explained by mathematical models in which the risk of cell death remains constant or decreases exponentially with age. These kinetics argue against the cumulative damage hypothesis; instead, the time of death of any neuron is random. Our findings are most simply accommodated by a ‘one-hit’ biochemical model in which mutation imposes a mutant steady state on the neuron and a single event randomly initiates cell death. This model appears to be common to many forms of neurodegeneration and has implications for therapeutic strategies.
Date: 2000
References: Add references at CitEc
Citations: View citations in EconPapers (3)
Downloads: (external link)
https://www.nature.com/articles/35018098 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:406:y:2000:i:6792:d:10.1038_35018098
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/35018098
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().